|
regulation of protein homooligomerization
|
GO_0032462 |
[Any process that modulates the frequency, rate or extent of protein homooligomerization.] |
|
negative regulation of protein homotetramerization
|
GO_1901094 |
[Any process that stops, prevents or reduces the frequency, rate or extent of protein homotetramerization.] |
|
negative regulation of protein homooligomerization
|
GO_0032463 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of protein homooligomerization.] |
|
positive regulation of protein homotetramerization
|
GO_1901095 |
[Any process that activates or increases the frequency, rate or extent of protein homotetramerization.] |
|
positive regulation of protein homooligomerization
|
GO_0032464 |
[Any process that activates or increases the frequency, rate or extent of protein homooligomerization.] |
|
regulation of autophagosome maturation
|
GO_1901096 |
[Any process that modulates the frequency, rate or extent of autophagosome maturation.] |
|
negative regulation of autophagosome maturation
|
GO_1901097 |
[Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome maturation.] |
|
positive regulation of autophagosome maturation
|
GO_1901098 |
[Any process that activates or increases the frequency, rate or extent of autophagosome maturation.] |
|
negative regulation of signal transduction in absence of ligand
|
GO_1901099 |
[Any process that stops, prevents or reduces the frequency, rate or extent of signal transduction in absence of ligand.] |
|
obsolete hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement
|
GO_0050800 |
[OBSOLETE. Catalysis of the hydrolysis of GTP to directly drive the cellular or subcellular transport of a substance.] |
|
diazepam binding
|
GO_0050809 |
[Binding to diazepam, one of the most widely used benzodiazepine drugs. It is used as an anti-anxiety-hypnotic agent and has the proprietary name Valium.] |
|
circadian sleep/wake cycle, sleep
|
GO_0050802 |
[The part of the circadian sleep/wake cycle where the organism is asleep.] |
|
sleep
|
GO_0030431 |
[Any process in which an organism enters and maintains a periodic, readily reversible state of reduced awareness and metabolic activity. Usually accompanied by physical relaxation, the onset of sleep in humans and other mammals is marked by a change in the electrical activity of the brain.] |
|
circadian sleep/wake cycle process
|
GO_0022410 |
[A behavioral process involved in the cycle from wakefulness through an orderly succession of sleep states and stages that occurs on an approximately 24 hour rhythm.] |
|
regulation of synapse structure or activity
|
GO_0050803 |
[Any process that modulates the physical form or the activity of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).] |
|
GABA receptor binding
|
GO_0050811 |
[Binding to a gamma-aminobutyric acid (GABA, 4-aminobutyrate) receptor.] |
|
coagulation
|
GO_0050817 |
[The process in which a fluid solution, or part of it, changes into a solid or semisolid mass.] |
|
epothilone metabolic process
|
GO_0050813 |
[The chemical reactions and pathways involving epothilone, a drug obtained from the myxobacteria Sporangium cellulosum that interferes with cell division. Some epothilones are being studied as treatments for cancer.] |
|
epothilone biosynthetic process
|
GO_0050814 |
[The chemical reactions and pathways resulting in the formation of epothilone, a drug obtained from the myxobacteria Sporangium cellulosum that interferes with cell division. Some epothilones are being studied as treatments for cancer.] |
|
phosphothreonine residue binding
|
GO_0050816 |
[Binding to a phosphorylated threonine residue within a protein.] |